Want to know what's happening next in healthcare?

MedCityNews is the leading online news source for the business of innovation in healthcare.


“I find MedCity News a great resource for taking the pulse of the market and sourcing potential investment opportunities.”

Bernie Rudnick, Angel investor and advisor, CapGenic Advisors, LLC


Sign up for our daily newsletter


Valentina Gburcik

Valentina Gburcik

Dr Valentina Gburcik is an analyst at GlobalData covering cardiovascular and metabolic disorders.

Follow Valentina Gburcik: Website |


End of the diabetes blockbuster: We are entering the “me-too” era

End of the diabetes blockbuster: We are entering the “me-too” era

May 30, 2013 7:12 am by | 1 Comments

Takeda announced positive late-stage results for its new type 2 diabetes drug, fasiglifam (TAK-875), the first GPR40 agonist to reach late-stage development. Fasiglifam has the potential to be a compelling…